Document is current

Article History

Received: 15 December 2024

Accepted: 2 June 2025

First Online: 16 June 2025

Declarations

:

: This research was approved by the HREC at the Western Sydney University (H15252).

: Not applicable.

: Author PH has received sessional fees from the Therapeutic Guidelines publication and the Health Education and Training Institute (HETI, NSW), and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, Blackwell Scientific Publications, BioMed Central, and PLOS Medicine. She has been a consultant to Takeda Pharmaceuticals and is on the Scientific Advisory Board of Tryptamine Therapeutics. Author GH was employed by ANZAED as the Credentialing Director for the Credential program with funding support from the Australian Government Department of Health and Aged Care. Author SM is the Past President of ANZAED and is the Chair of the ANZAED Credentialing Governing Council. The authors KP, JC, MM, and RB declare that they have no competing interests.

: KP is an Adjunct Research Fellow in the School of Medicine at Western Sydney University and a Postdoctoral Research Fellow at the Graduate School of Health at the University of Technology Sydney, JC is an Associate Professor of Clinical Psychology at Western Sydney University, MM is a Research Officer at Western Sydney University, GH is an Adjunct Associate Professor of Medicine at Western Sydney University and Credentialing Director for ANZAED, RB is a Research Officer at Western Sydney University, SM is a Senior Lecturer in the Department of Psychology, Counselling & Therapy at La Trobe University, and PH is a Professor of Medicine at Western Sydney University.

: This article has been published as part of Journal of Eating Disorders Volume 13 Supplement 1, 2025: The Australia & New Zealand Academy for Eating Disorders. The full contents of the supplement are available online at: .